ACUTA CAPITAL PARTNERS, LLC Hedge Fund

Location: Redwood City, CA

CIK: 0001582844 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 14, 2022

Total Value: $238M (100.0% shares, 0.0% debt)

Holdings (36)

WHWK AADI BIOSCIENCES INC 15.5%
Value $36.94M Shares 1,529,402 Est. Cost $30.48 Unrealized -17.6%
APLS APELLIS PHARMACEUTICALS INC 10.6%
Value $25.3M Shares 535,000 Est. Cost $38.80 Unrealized +1.5%
VISTAGEN THERAPEUTICS INC 9.6%
Value $22.89M Shares 11,736,283 Est. Cost $2.01 Unrealized
CLDX CELLDEX THERAPEUTICS INC 5.5%
Value $13.14M Shares 340,098 Est. Cost $7.56 Unrealized +476.6%
GHRS GH RESEARCH PLC 4.1%
Value $9.79M Shares 419,632 Est. Cost $20.48 Unrealized +7.3%
RLMD RELMADA THERAPEUTICS INC 3.8%
Value $9.102M Shares 404,000 Est. Cost $22.24 Unrealized 0.0%
BCLS ACQUISITION CORP- CL A 3.5%
Value $8.263M Shares 843,122 Est. Cost $11.14 Unrealized
IVERIC BIO INC 3.3%
Value $7.858M Shares 470,000 Est. Cost $6.17 Unrealized
MERUS BV 3.1%
Value $7.489M Shares 235,500 Est. Cost $26.72 Unrealized
PYXS PYXIS ONCOLOGY INC SERIES B 3.1%
Value $7.435M Shares 677,753 Est. Cost $11.45 Unrealized 0.0%
XENE XENON PHARMACEUTICALS INC 3.0%
Value $7.029M Shares 225,000 Est. Cost $15.28 Unrealized +95.5%
ARWR ARROWHEAD PHARMACEUTICALS INC 2.9%
Value $6.995M Shares 105,500 Est. Cost $43.08 Unrealized +59.5%
VRDN VIRIDIAN THERAPEUTICS INC 2.6%
Value $6.287M Shares 318,000 Est. Cost $16.94 Unrealized +10.0%
JIYA ACQUISITION CORP -CL A 2.3%
Value $5.496M Shares 562,500 Est. Cost $10.30 Unrealized
AVADEL PHARMACEUTICALS PLC 2.0%
Value $4.686M Shares 580,000 Est. Cost $8.08 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 1.9%
Value $4.512M Shares 206,126 Est. Cost $17.89 Unrealized +3.3%
CYTEIR THERAPEUTICS INC 1.9%
Value $4.457M Shares 391,974 Est. Cost $20.28 Unrealized
BELLUS HEALTH INC 1.8%
Value $4.226M Shares 525,000 Est. Cost $6.14 Unrealized
KURA KURA ONCOLOGY INC. COMMON STOCK 1.7%
Value $4.086M Shares 291,884 Est. Cost $15.54 Unrealized +4.3%
SEELOS THERAPEUTICS INC 1.7%
Value $4.075M Shares 2,500,000 Est. Cost $4.05 Unrealized
ATHIRA PHARMA INC 1.7%
Value $4.04M Shares 310,030 Est. Cost $18.82 Unrealized
HEALTH SCIENCES ACQUISITIONS 1.7%
Value $3.956M Shares 392,500 Est. Cost $11.00 Unrealized
VERASTEM INC 1.6%
Value $3.823M Shares 1,865,000 Est. Cost $2.55 Unrealized
FULC FULCRUM THERAPEUTICS INC 1.5%
Value $3.538M Shares 200,000 Est. Cost $11.72 Unrealized +69.1%
IOVA IOVANCE BIOTHERAPEUTICS INC 1.4%
Value $3.436M Shares 179,995 Est. Cost $21.92 Unrealized +0.4%
ALPINE IMMUNE SCIENCES INC 1.3%
Value $3.186M Shares 230,000 Est. Cost $13.85 Unrealized
EYPT EYEPOINT PHARMACEUTICALS INC 1.3%
Value $2.975M Shares 243,072 Est. Cost $11.25 Unrealized +19.6%
MIRATI THERAPEUTICS 1.2%
Value $2.934M Shares 20,000 Est. Cost $146.70 Unrealized
ALDX ALDEYRA THERAPEUTICS INC 0.8%
Value $2M Shares 500,000 Est. Cost $7.63 Unrealized 0.0%
SIERRA ONCOLOGY INC 0.6%
Value $1.489M Shares 68,500 Est. Cost $21.74 Unrealized
ACRS ACLARIS THERAPEU 0.6%
Value $1.425M Shares 98,000 Est. Cost $19.56 Unrealized -22.5%
GOSS GOSSAMER BIO INC 0.6%
Value $1.355M Shares 119,843 Est. Cost $9.21 Unrealized +29.0%
MOLECULAR TEMPLATES INC 0.5%
Value $1.264M Shares 322,500 Est. Cost $3.92 Unrealized
GRTX GALERA THERAPEUTICS INC 0.5%
Value $1.205M Shares 262,500 Est. Cost $3.31 Unrealized 0.0%
JOUNCE THERAPEUTICS INC 0.4%
Value $1.065M Shares 127,500 Est. Cost $8.35 Unrealized
NUVB Nuvation Warrants 0.1%
Value $172K Shares 90,832 Est. Cost $9.19 Unrealized 0.0%